Skip to main content
Fig. 4 | Stem Cell Research & Therapy

Fig. 4

From: Clinical efficacy and safety of multipotent adult progenitor cells (invimestrocel) for acute respiratory distress syndrome (ARDS) caused by pneumonia: a randomized, open-label, standard therapy–controlled, phase 2 multicenter study (ONE-BRIDGE)

Fig. 4

a Interleukin-6 and b C-reactive protein plasma concentrations over time (modified intent-to-treat analysis set). Data are presented as medians with upper and lower quartiles. Baseline is defined as the last measurement on day 0 pre-treatment or before (day − 3 to − 1). ARDS acute respiratory distress syndrome, BL baseline, CRP C-reactive protein, IL-6 interleukin-6

Back to article page

Stem Cell Research & Therapy

ISSN: 1757-6512